Research Article
Serum Prolidase Activity and Oxidative Stress in Diabetic Nephropathy and End Stage Renal Disease: A Correlative Study with Glucose and Creatinine
Table 2
Representation of SPA, TAS, TOS, and OSI for cases and controls.
| | Subjects/parameters | Control-1
( = 50) | Control-2
( = 50) | Case-1
( = 86) | Case-2
( = 43) | ANOVA
(Sig./) |
| SPA
(mmol min−1 L−1) | 55.72 ± 7.90
( = 47.32 to 78.34) | 60.18 ± 7.85
( = 45 to 82) | 68.56 ± 11.09
( = 47.49 to 89.42) | 74.23 ± 13.22
( = 56 to 96) | = 32.14
0.001 | TAS
(mmol Trolox Eq/L) | 1.97 ± 0.51
( = 0.81 to 2.91) | 1.82 ± 0.43
( = 0.95 to 2.76) | 1.42 ± 0.39
( = 0.78 to 2.25) | 1.20 ± 0.45
( = 0.63 to 1.98) | = 32.99
0.001 | TOS
(µmol H2O2 Eq/L) | 13.82 ± 2.14
( = 9.88 to 17.71) | 17.54 ± 2.46
( = 12.74 to 28.91) | 20.13 ± 3.75
( = 12.50 to 34.0) | 22.21 ± 3.66
( = 15.34 to 31.0) | = 64.47
0.001 | OSI
(arbitrary unit) | 8.02 ± 4.21
( = 3.41 to 21.86) | 10.58 ± 4.58
( = 5.04 to 29.50) | 16.04 ± 7.58
( = 5.55 to 42.50) | 22.09 ± 10.21
( = 7.87 to 47.69) | = 37.21
0.001 |
|
|
